{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:38:48Z","timestamp":1790732328089,"version":"4.1.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"AstraZeneca Pharmaceuticals LP and Pfizer, Inc"},{"name":"INFORM"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To determine the spread of ESBLs and carbapenemases in Enterobacterales and Pseudomonas aeruginosa in Europe.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>45\u2009335 Gram-negative bacilli were collected in 18 European countries as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance programme from 2013 to 2017. Antimicrobial susceptibility was determined using broth microdilution, and 9546 isolates were screened for \u03b2-lactamase genes by PCR and sequencing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>ESBLs were identified in 35.5% of Klebsiella pneumoniae and 18.5% of Escherichia coli. ESBL carriage was lowest among isolates in Northern\/Western Europe and highest in Eastern Europe. CTX-M-15 was the dominant ESBL in all countries except Greece, where SHV-type ESBLs were more common. Carbapenemases (KPC, OXA-48-like, GES, NDM and VIM) were found in 3.4% of Enterobacterales and were most common among K. pneumoniae (10.5% of those collected). Carbapenemase carriage was lowest in Northern\/Western and highest in Southern Europe. KPC-positive Enterobacterales were most abundant but the percentages of OXA-48-like-, NDM- and VIM-positive isolates increased over time and were correlated with an increase in meropenem non-susceptibility. Carbapenemases (VIM, IMP, NDM and GES) were also identified in 5.1% of P. aeruginosa and were commonly found in Eastern Europe. Carbapenemase carriage and meropenem non-susceptibility among P. aeruginosa fluctuated over the 5\u2009years studied and were not well correlated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>ESBL and carbapenemase carriage varied by species and European subregion. Meropenem non-susceptibility in European isolates of Enterobacterales can be attributed to carbapenemase carriage and is increasingly caused by MBLs and OXA-48-like carbapenemases. Carbapenemases or other \u03b2-lactamases are not a common cause of meropenem non-susceptibility in P. aeruginosa in Europe.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkz571","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T20:10:06Z","timestamp":1577736606000},"page":"1165-1173","source":"Crossref","is-referenced-by-count":73,"title":["Longitudinal analysis of ESBL and carbapenemase carriage among Enterobacterales and Pseudomonas aeruginosa isolates collected in Europe as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance programme, 2013\u201317"],"prefix":"10.1093","volume":"75","author":[{"given":"Krystyna M","family":"Kazmierczak","sequence":"first","affiliation":[{"name":"International Health Management Associates, Inc., Schaumburg, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boudewijn L M","family":"de Jonge","sequence":"first","affiliation":[{"name":"Pfizer, Inc., Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory G","family":"Stone","sequence":"first","affiliation":[{"name":"Pfizer, Inc., Groton, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F","family":"Sahm","sequence":"first","affiliation":[{"name":"International Health Management Associates, Inc., Schaumburg, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"key":"2020042304564545000_dkz571-B1","year":"2017"},{"key":"2020042304564545000_dkz571-B2","year":"2014"},{"key":"2020042304564545000_dkz571-B3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jgar.2013.01.005","article-title":"Carbapenemases: partners in crime","volume":"1","author":"Bush","year":"2013","journal-title":"J Glob Antimicrob Resist"},{"key":"2020042304564545000_dkz571-B4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2020042304564545000_dkz571-B5","doi-asserted-by":"crossref","first-page":"e01076","DOI":"10.1128\/AAC.01076-18","article-title":"Past and present perspectives on \u03b2-lactamases","volume":"62","author":"Bush","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020042304564545000_dkz571-B6","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1128\/AAC.48.8.3203-3206.2004","article-title":"Role of \u03b2-lactamases and porins in resistance to ertapenem and other \u03b2-lactams in Klebsiella pneumoniae","volume":"48","author":"Jacoby","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2020042304564545000_dkz571-B7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jac\/dkp029","article-title":"Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK","volume":"63","author":"Doumith","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/338782","article-title":"Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?","volume":"34","author":"Livermore","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2020042304564545000_dkz571-B9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"2020042304564545000_dkz571-B10","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/jac\/dky267","article-title":"In vitro activity of ceftazidime\/avibactam against isolates of Pseudomonas aeruginosa collected in European countries: INFORM global surveillance 2012\u201315","volume":"73","author":"Kazmierczak","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B11","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/jac\/dky266","article-title":"In vitro activity of ceftazidime\/avibactam against isolates of Enterobacteriaceae collected in European countries: INFORM global surveillance 2012\u201315","volume":"73","author":"Kazmierczak","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B12","year":"2015"},{"key":"2020042304564545000_dkz571-B13","year":"2018"},{"key":"2020042304564545000_dkz571-B14","year":"2018"},{"key":"2020042304564545000_dkz571-B15","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1128\/AAC.05186-14","article-title":"Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013","volume":"59","author":"Lob","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2020042304564545000_dkz571-B16","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1128\/AAC.00220-16","article-title":"In vitro susceptibility of global surveillance isolates of Pseudomonas aeruginosa to ceftazidime\u2013avibactam (INFORM 2012 to 2014)","volume":"60","author":"Nichols","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2020042304564545000_dkz571-B17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","article-title":"Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study","volume":"17","author":"Grundmann","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2020042304564545000_dkz571-B18","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1128\/AAC.01513-13","article-title":"Carbapenemase-producing Enterobacteriaceae in Spain in 2012","volume":"57","author":"Oteo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2020042304564545000_dkz571-B19","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.6.30461","article-title":"Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014","volume":"22","author":"Dortet","year":"2017","journal-title":"Euro Surveill"},{"key":"2020042304564545000_dkz571-B20","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.19.30530","article-title":"Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015","volume":"22","author":"Huang","year":"2017","journal-title":"Euro Surveill"},{"key":"2020042304564545000_dkz571-B21","first-page":"1054","article-title":"Characterization of carbapenemase-producing Enterobacteriaceae in the West Midlands region of England: 2007\u201314","volume":"72","author":"Findlay","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B22","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.31.30583","article-title":"Evolving \u03b2-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients","volume":"22","author":"Giani","year":"2017","journal-title":"Euro Surveill"},{"key":"2020042304564545000_dkz571-B23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/dkl483","article-title":"CTX-M: changing the face of ESBLs in Europe","volume":"59","author":"Livermore","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B24","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/jac\/dkx146","article-title":"Global epidemiology of CTX-M \u03b2-lactamases: temporal and geographical shifts in genotype","volume":"72","author":"Bevan","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fmicb.2012.00110","article-title":"CTX-M enzymes: origin and diffusion","volume":"3","author":"Canton","year":"2012","journal-title":"Front Microbiol"},{"key":"2020042304564545000_dkz571-B26","doi-asserted-by":"crossref","first-page":"e00377","DOI":"10.1128\/mBio.00377-13","article-title":"The epidemic of extended-spectrum-\u03b2-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx","volume":"4","author":"Price","year":"2013","journal-title":"mBio"},{"key":"2020042304564545000_dkz571-B27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/jac\/dkn287","article-title":"Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type \u03b2-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005\u2014the new \u2018MRSAs\u2019?","volume":"62","author":"Damjanova","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijantimicag.2011.03.020","article-title":"High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination","volume":"38","author":"Lee","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"2020042304564545000_dkz571-B29","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/jac\/dkv485","article-title":"Diversity of STs, plasmids and ESBL genes among Escherichia coli from humans, animals and food in Germany, the Netherlands and the UK","volume":"71","author":"Day","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B30","doi-asserted-by":"crossref","first-page":"e01911","DOI":"10.1128\/AAC.01911-16","article-title":"Inventory of extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae in France as assessed by a multicentre study","volume":"61","author":"Robin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2020042304564545000_dkz571-B31","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3201\/eid2211.160519","article-title":"Global Escherichia coli Sequence Type 131 clade with blaCTX-M-27 gene","volume":"22","author":"Matsumura","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2020042304564545000_dkz571-B32","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3201\/eid2310.170938","article-title":"bla\n            CTX-M-27-encoding Escherichia coli Sequence Type 131 lineage C1-M27 clone in clinical isolates, Germany","volume":"23","author":"Ghosh","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2020042304564545000_dkz571-B33","doi-asserted-by":"crossref","first-page":"885.","DOI":"10.3201\/eid2305.161865","article-title":"CTX-M-27-producing Escherichia coli of Sequence Type 131 and clade C1-M27, France","volume":"23","author":"Birgy","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2020042304564545000_dkz571-B34","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1093\/jac\/dky296","article-title":"Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe","volume":"73","author":"Merino","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","article-title":"Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe","volume":"18","author":"Canton","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2020042304564545000_dkz571-B36","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.28.20525","article-title":"Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013","volume":"18","author":"Glasner","year":"2013","journal-title":"Euro Surveill"},{"key":"2020042304564545000_dkz571-B37","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2015.20.45.30062","article-title":"Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015","volume":"20","author":"Albiger","year":"2015","journal-title":"Euro Surveill"},{"key":"2020042304564545000_dkz571-B38","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.9.1900123","article-title":"Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018","volume":"24","author":"Brolund","year":"2019","journal-title":"Euro Surveill"},{"key":"2020042304564545000_dkz571-B39","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1093\/jac\/dkw321","article-title":"The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones of Klebsiella pneumoniae ST11\/KPC-2, ST101\/KPC-2 and ST512\/KPC-3","volume":"71","author":"Oteo","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B40","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.25.30262","article-title":"Active surveillance scheme in three Romanian hospitals reveals a high prevalence and variety of carbapenemase-producing Gram-negative bacteria: a pilot study, December 2014 to May 2015","volume":"21","author":"Timofte","year":"2016","journal-title":"Euro Surveill"},{"key":"2020042304564545000_dkz571-B41","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/jac\/dkx012","article-title":"OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014","volume":"72","author":"Findlay","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B42","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/jac\/dkx054","article-title":"Multiregional dissemination of KPC-producing Klebsiella pneumoniae ST258\/ST512 genotypes in Poland, 2010\u201314","volume":"72","author":"Baraniak","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B43","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.5.1800159","article-title":"Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017","volume":"24","author":"Iacchini","year":"2019","journal-title":"Euro Surveill"},{"key":"2020042304564545000_dkz571-B44","doi-asserted-by":"crossref","first-page":"548960.","DOI":"10.1155\/2014\/548960","article-title":"Detection of carbapenemase-producing Enterobacteriaceae in the Baltic countries and St. Petersburg area","volume":"2014","author":"Pavelkovich","year":"2014","journal-title":"BioMed Res Int"},{"key":"2020042304564545000_dkz571-B45","doi-asserted-by":"crossref","first-page":"46.","DOI":"10.1186\/s12941-015-0108-y","article-title":"The spread of blaOXA-48 and blaOXA-244 carbapenemase genes among Klebsiella pneumoniae, Proteus mirabilis, and Enterobacter spp. isolated in Moscow, Russia","volume":"14","author":"Fursova","year":"2015","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2020042304564545000_dkz571-B46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/dku339","article-title":"Dominance of international \u2018high-risk clones\u2019 among metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa in the UK","volume":"70","author":"Wright","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B47","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/jac\/dku048","article-title":"Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009\u201311 in 14 European and Mediterranean countries","volume":"69","author":"Castanheira","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B48","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1473-3099(13)70168-3","article-title":"Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study","volume":"13","author":"Edelstein","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2020042304564545000_dkz571-B49","doi-asserted-by":"crossref","first-page":"e01811","DOI":"10.1128\/AAC.01811-17","article-title":"Molecular characterization of carbapenemase-producing Pseudomonas aeruginosa of Czech origin and evidence for clonal spread of extensively resistant Sequence Type 357 expressing IMP-7 metallo-\u03b2-lactamase","volume":"61","author":"Papagiannitsis","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2020042304564545000_dkz571-B50","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jac\/dku391","article-title":"Characterization of a new genetic environment associated with GES-6 carbapenemase from a Pseudomonas aeruginosa isolate belonging to the high risk clone ST235","volume":"70","author":"Botelho","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2020042304564545000_dkz571-B51","doi-asserted-by":"crossref","first-page":"e01589","DOI":"10.1128\/AAC.01589-17","article-title":"Genomics and susceptibility profiles of extensively-drug resistant Pseudomonas aeruginosa isolates from Spain","volume":"61","author":"Del Barrio-Tofino","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2020042304564545000_dkz571-B52","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/jac\/dkx453","article-title":"Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane\/tazobactam and comparators, and molecular epidemiology of carbapenemase producers","volume":"73","author":"Giani","year":"2018","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/5\/1165\/33112818\/dkz571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/5\/1165\/33112818\/dkz571.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T08:58:17Z","timestamp":1587632297000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/75\/5\/1165\/5732856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,2,10]]},"published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz571","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,5]]},"published":{"date-parts":[[2020,2,10]]}}}